Literature DB >> 3987486

Antibiotic treatment of neonates--does route of administration matter?

A Mulhall.   

Abstract

The pharmacokinetics of gentamicin (19 babies), benzylpenicillin (7 babies), mecillinam (15 babies), cefuroxime (15 babies), ceftriaxone (37 babies), and latamoxef (27 babies) were compared following intravenous or intramuscular administration in the neonate. The effect of oral or intravenous administration of chloramphenicol was examined in 47 babies. The pharmacokinetics following either intravenous or intramuscular administration were essentially the same. Cmax was equivalent after both routes except for gentamicin (Cmax higher following intravenous administration) and latamoxef (Cmax lower following intravenous administration). Although Tmax ranged between 0.4 and 1.5 h therapeutically effective serum concentrations were attained within 15 min of intramuscular administration of all antibiotics. Clinical rather than pharmacokinetic considerations should therefore dictate which route should be used. Oral administration of chloramphenicol resulted in significantly lower steady-state serum concentrations and therefore this route should be avoided in the young premature neonate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987486     DOI: 10.1159/000457016

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  10 in total

1.  Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks.

Authors:  Anouk E Muller; Joost DeJongh; Ymka Bult; Wil H F Goessens; Johan W Mouton; Meindert Danhof; John N van den Anker
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 2.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

3.  [Experiences with ceftazidime in the therapy of neonatal infections].

Authors:  J de Louvois
Journal:  Infection       Date:  1987       Impact factor: 3.553

Review 4.  Clinical pharmacokinetics of antibacterial drugs in neonates.

Authors:  C M Paap; M C Nahata
Journal:  Clin Pharmacokinet       Date:  1990-10       Impact factor: 6.447

5.  Evaluation of a System-Specific Function To Describe the Pharmacokinetics of Benzylpenicillin in Term Neonates Undergoing Moderate Hypothermia.

Authors:  Yuma A Bijleveld; Timo R de Haan; Johanna H van der Lee; Floris Groenendaal; Peter H Dijk; Arno van Heijst; Rogier C J de Jonge; Koen P Dijkman; Henrica L M van Straaten; Monique Rijken; Inge A Zonnenberg; Filip Cools; Alexandra Zecic; Debbie H G M Nuytemans; Anton H van Kaam; Ron A A Mathôt
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 6.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

7.  Pharmacokinetics of Penicillin G in Preterm and Term Neonates.

Authors:  Helgi Padari; Tuuli Metsvaht; Eva Germovsek; Charlotte I Barker; Karin Kipper; Koit Herodes; Joseph F Standing; Kersti Oselin; Tõnis Tasa; Hiie Soeorg; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

8.  Oral antibiotics for neonatal infections: a systematic review and meta-analysis.

Authors:  Fleur M Keij; René F Kornelisse; Nico G Hartwig; Irwin K M Reiss; Karel Allegaert; Gerdien A Tramper-Stranders
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790

Review 9.  Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries.

Authors:  Gary L Darmstadt; Mary Miller-Bell; Maneesh Batra; Paul Law; Kiely Law
Journal:  J Health Popul Nutr       Date:  2008-06       Impact factor: 2.000

10.  Ceftriaxone Absorption Enhancement for Noninvasive Administration as an Alternative to Injectable Solutions.

Authors:  Boubakar Ba; Karen Gaudin; Amélie Désiré; Thida Phoeung; Marie-Hélène Langlois; Charan R Behl; Joel Unowsky; Indravadan H Patel; A Waseem Malick; Melba Gomes; Nicholas White; Tina Kauss
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.